has been cited by the following article(s):
|
[1]
|
Tata Memorial Centre Textbook of Oncology
2024
DOI:10.1007/978-981-99-3378-5_60
|
|
|
|
|
[2]
|
Outcomes with Methotrexate-Free Dyad Chemotherapy in Osteosarcoma Patients: Audit from a Resource-Limited Setting
Indian Journal of Medical and Paediatric Oncology,
2024
DOI:10.1055/s-0044-1795133
|
|
|
|
|
[3]
|
Resource‐appropriate selection of osteosarcoma treatment protocols in low‐ and middle‐income countries
Pediatric Blood & Cancer,
2022
DOI:10.1002/pbc.29540
|
|
|
|
|
[4]
|
Osteosarcoma journey in India: Each step reveals a new horizon!
Indian Journal of Medical and Paediatric Oncology,
2020
DOI:10.4103/ijmpo.ijmpo_15_20
|
|
|
|
|
[5]
|
Osteosarcoma journey over two decades in India: Small steps, big changes
Pediatric Blood & Cancer,
2019
DOI:10.1002/pbc.27877
|
|
|
|
|
[6]
|
Speed and Safety in Drug Approval and Commercialization
Pediatrics,
2017
DOI:10.1542/peds.2017-0791
|
|
|
|
|
[7]
|
Ionizing radiation received by patients with osteosarcoma during intra-arterial chemotherapy treatment
Anales del Sistema Sanitario de Navarra,
2017
DOI:10.23938/ASSN.0009
|
|
|
|